People: ACADIA Pharmaceuticals Inc (ACAD.O)

ACAD.O on Nasdaq

23.98USD
29 Aug 2014
Price Change (% chg)

$0.37 (+1.57%)
Prev Close
$23.61
Open
$23.61
Day's High
$24.14
Day's Low
$23.58
Volume
636,507
Avg. Vol
989,382
52-wk High
$32.00
52-wk Low
$15.64

Search Stocks

Borer, Michael 

Brief Biography

Mr. Michael T. Borer is Independent Director of ACADIA Pharmaceuticals, Inc. Mr. Borer served as Chief Executive Officer and President of Xcel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on prescription products that treat disorders of the central nervous system, until the sale of the company to Valeant Pharmaceuticals International in early 2005. Prior to founding Xcel in early 2001, Mr. Borer served as Senior Vice President and Chief Financial Officer of Dura Pharmaceuticals, Inc. and held other management positions there from 1994 through 2000. Prior to Dura, Mr. Borer spent 12 years in public accounting with Deloitte & Touche in its audit services group. The NCG Committee believes that Mr. Borer’s industry background, including his experience as chief executive officer and other executive officer positions of public companies in the biotechnology industry, position him to make an effective contribution to the Board. In addition, his public accounting experience and past financial officer positions are very valuable to fulfilling the Audit Committee’s responsibilities. He holds a bachelor’s degree in accounting from San Diego State University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leslie Iversen

--

Uli Hacksell

4,818,870

Stephen Davis

--

Roger Mills

2,876,290

Terrence Moore

2,452,450

Glenn Baity

2,135,770
As Of 30 Dec 2013
Search Stocks